Nitro Pro
Nitro Pro, licence 80134719: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Canpower Health AminoPRO, Canpower Health NitroBOOST, NOSBoost, NOSPlus, NitroBlast, NitroZone, WOMENOnly NitroFit
- Licence holder
- Natra Labs Ltd.
- NPN or DIN-HM
- 80134719
- Status
- Active licence
- Licence date
- 27 September 2024
- Revision date
- 17 March 2026
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| bêta-Hydroxy-bêta-méthylbutyrate de calcium Source : Bêta-hydroxy-bêta-méthylbutyrate de calcium | 50.0 mg | Not calculated |
| L-Citrulline Source : L-Citrulline malate | 150.0 mg | Not calculated |
| Acide 3-aminopropanoïque Source : Beta-alanine | 100.0 mg | Not calculated |
| L-théanine Source : L-Théanine | 50.0 mg | Not calculated |
| Beta vulgaris Source : Beta vulgaris - Racine | 100.0 mg | Not calculated |
Non-medicinal ingredients
Acide stéarique, Dioxyde de silicium, Hypromellose, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 Année(s) | 2.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to temporarily promote relaxation. Source of (an) (non-essential) amino acid(s) involved in muscle protein synthesis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80134719
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.